Compare Exelixis Inc. Common Stock (EXEL) vs Invesco S&P 500 Low Volatility ETF (SPLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs Invesco S&P 500 Low Volatility ETF — how do they compare? Exelixis Inc. Common Stock trades at $60 (market cap $14.62B), while Invesco S&P 500 Low Volatility ETF trades at $72.03 (market cap $6.94B). The key difference: Exelixis Inc. Common Stock is far larger — about 2.1× Invesco S&P 500 Low Volatility ETF's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, Invesco S&P 500 Low Volatility ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Invesco S&P 500 Low Volatility ETF for 123 Days on average.
| EXEL | SPLV | |
|---|---|---|
Market Cap | $14.62B | $6.94B |
Volume | 2,684,957 | 1,663,703 |
Sector | Health | — |
52-Week High | $59.13 | $77.97 |
52-Week Low | $34.54 | $70.30 |
Typical Hold Time | 0 Days | 123 Days |
Enterprise Value | $13.95B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPLV trades at $71.99, up 1.08% with a bearish technical outlook from moving averages. The ETF's sector overweights in Utilities, Real Estate, and Financials have contributed to underperformance versus the S&P 500. Recent dividend payments of $0.14 provide income support, while technical indicators show mixed signals with neutral oscillators.
Outlook remains cautious due to sector headwinds and unappealing growth-adjusted valuation. The fund's low-volatility focus offers defensive positioning amid market uncertainty, though continued underperformance relative to broader market indexes presents near-term challenges for total return investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About Invesco S&P 500 Low Volatility ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the "index Provider") compiles, maintains and calculates the underlying index, which is designed to measure the performance of the 100 least volatile constituents of the S&P 500 ® Index over the past 12 months as determined by the index Provider.
Read more on SPLV →
